These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7083729)

  • 41. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
    Hashimoto K; Satoh H; Shibuya T; Imai S
    J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Utilization of anti-arrhythmic drugs].
    Perrenoud JJ
    Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Kawade M; Arakaki Y; Aihara N; Kamakura S; Kamiya T; Shimomura K
    J Am Coll Cardiol; 1995 Nov; 26(5):1299-309. PubMed ID: 7594047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Complications after intravenous administration of anti-arrhythmia agents].
    Anshelevich IuV; Dumesh SZ; Slaĭdyn' AK; Sporan VG
    Kardiologiia; 1982 Nov; 22(11):19-22. PubMed ID: 7154501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The assessment of antidysrhythmic drugs.
    Levitt B
    J Clin Pharmacol; 1984 Jul; 24(7):328-32. PubMed ID: 6384278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of beta-adrenergic blocking agents in the therapy of cardiac arrhythmias].
    Streian C; Hodas C; Gavrilescu S
    Med Interna (Bucur); 1974 May; 26(5):583-92. PubMed ID: 4152240
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Symposium on anti-arrhythmic drugs of the Swedish Society of Cardiology].
    Lakartidningen; 1973 Dec; 70(50):4665-77. PubMed ID: 4152516
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic drug monitoring of antiarrhythmic agents.
    Brown JE; Shand DG
    Clin Pharmacokinet; 1982; 7(2):125-48. PubMed ID: 7039925
    [No Abstract]   [Full Text] [Related]  

  • 52. Dose-ranging studies of clofilium, an antiarrhythmic quaternary ammonium.
    Platia EV; Reid PR
    Clin Pharmacol Ther; 1984 Feb; 35(2):193-202. PubMed ID: 6692647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propranolol and lidocaine. Clinical use as antiarrhythmic agents.
    Danahy DT; Aronow WS
    Postgrad Med; 1977 Jan; 61(1):113-7. PubMed ID: 834676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implications of aging in the treatment of complex arrhythmias.
    Chatzidou S; Georgiopoulos G; Kontogiannis C
    Aging (Albany NY); 2018 Oct; 10(11):3048-3049. PubMed ID: 30368231
    [No Abstract]   [Full Text] [Related]  

  • 57. Potential organ- or tumor-imaging agents XIX: radioiodinated antiarrhythmic drugs as potential myocardial imaging agents.
    Korn N; Gibson JK; Kniffen FJ; Lucchesi BR; Ranade VV; Mimnaugh M; Yu T; Counsell RE
    J Pharm Sci; 1980 Sep; 69(9):1010-3. PubMed ID: 6106052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propranolol and depression revisited: three cases and a review.
    Pollack MH; Rosenbaum JF; Cassem NH
    J Nerv Ment Dis; 1985 Feb; 173(2):118-9. PubMed ID: 3968546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Berlin A; Treiber LR
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):277-82. PubMed ID: 1233225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seizures and intraventricular conduction defect in propranolol poisoning. A report of two cases.
    Buiumsohn A; Eisenberg ES; Jacob H; Rosen N; Bock J; Frishman WH
    Ann Intern Med; 1979 Dec; 91(6):860-2. PubMed ID: 517885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.